Cost effectiveness of ACE inhibitor treatment for patients with type 1 diabetes mellitus.
Dong
Frederick B
FB
Battelle, Centers for Public Health Research and Evaluation, Seattle, Washington, USA.
Sorensen
Stephen W
SW
Manninen
Diane L
DL
Thompson
Theodore J
TJ
Narayan
Venkat
V
Orians
Carlyn E
CE
Gregg
Edward W
EW
Eastman
Richard C
RC
Dasbach
Erik J
EJ
Herman
William H
WH
Newman
Jeffrey M
JM
Narva
Andrew S
AS
Ballard
David J
DJ
Engelgau
Michael M
MM
D000328:Adult; D000367:Age Factors; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000191:economics* / Q000627:therapeutic use; D002216:Captopril / Q000191:economics* / Q000627:therapeutic use; D015331:Cohort Studies; D003362:Cost-Benefit Analysis; D048909:Diabetes Complications / Q000191:economics / Q000517:prevention & control; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy / Q000191:economics*; D006801:Humans; D008390:Markov Chains; D018803:Models, Economic; D009010:Monte Carlo Method; D011788:Quality of Life; D016896:Treatment Outcome; D014481:United States
D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril